Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

NUWE - Nuwellis, Inc. Latest News | Finranks

Home

/

NUWE

N

Nuwellis, Inc. (NUWE)

NCM – Real Time Price. Currency in USD

1.40

-0.07 (-5.07%)

Market open: Aug 12, 2026, 2:28 PM EDT

1.49

+0.01 (0.68%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer

Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer

MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of Dale Brady as Principal R&D Engineer. Brady brings more than 25 years of medical device leadership experience in research and development, operations, manufacturing, quality systems and commercialization, with a proven track record of advancing innovative products from concept through commercial launch.

Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications

Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications

Development initiatives to strategically extend Aquadex® platform capabilities for future immunomodulation, extracorporeal blood purification, and advanced critical care therapies Development initiatives to strategically extend Aquadex® platform capabilities for future immunomodulation, extracorporeal blood purification, and advanced critical care therapies

Videos

No Data

There is no data to display

Press releases

Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer

Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer

MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of Dale Brady as Principal R&D Engineer. Brady brings more than 25 years of medical device leadership experience in research and development, operations, manufacturing, quality systems and commercialization, with a proven track record of advancing innovative products from concept through commercial launch.

Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications

Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications

Development initiatives to strategically extend Aquadex® platform capabilities for future immunomodulation, extracorporeal blood purification, and advanced critical care therapies Development initiatives to strategically extend Aquadex® platform capabilities for future immunomodulation, extracorporeal blood purification, and advanced critical care therapies